Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001096906-11-001062
Filing Date
2011-05-26
Accepted
2011-05-26 14:22:35
Documents
1
Period of Report
2011-06-30
Effectiveness Date
2011-05-26

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. DEFINITIVE PROXY axndef14a20110630.htm DEF 14A 481855
  Complete submission text file 0001096906-11-001062.txt   483231
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-32674 | Film No.: 11873544
SIC: 2834 Pharmaceutical Preparations